HBI Spotlight

 

EMEA hospital sector finishes 2020 strongly

Private hospital operators across Europe, the Middle East and South Africa had a good last few months of trading in what was a turbulent 2020, but the start of 2021 looks tougher. We talk to operators across the region.

Synlab and Cerba looking for exits, while Unilabs in ‘no rush’

The COVID-19 pandemic has uniquely warped revenue for the big lab groups. Difficulty forecasting means Apax is in “no rush” to explore an exit while Cerba Healthcare may join Synlab in an IPO process, HBI can reveal. Synlab is reportedly on an IPO roadshow this week and Biogroup’s recent record-breaking raise on the bond market shows there’s an investor appetite. 

NHS reform could give patients choice to seek private care

Population health is at the centre of a new NHS England reform that will give purchasing power to local, integrated health bodies across the UK. At first glance, the white paper points to less work for the private sector, but a new procurement system could tip it towards the system seen in Europe, where the local body often acts as a payor and the patient has a much wider choice of provider.

NMC CEO: Any sale will be a competitive, traditional process

Will the creditors of NMC Healthcare, the GCC's largest for-profit healthcare operator which has been in administration since April 2020, choose a sale of its core UAE business in the next 3-6 months or a longer-term, creditor-led restructuring? We talk exclusively to NMC CEO Michael Davis and UAE sources. A 'fire sale' of parts of its core UAE business now seems entirely off the table.

Ameos “prepares for sale or refinancing”

Multiple sources tell HBI that DACH psychiatry and acute hospital group Ameos is preparing for sale or refinancing. The group vehemently denies it is preparing for sale.

Appointment of new Artemis CEO lends weight to sale rumours

The CEO of Artemis Group, Germany's second largest ophthalmology chain by revenue, is stepping down from his position as CEO next week to be replaced by the former MD of German rehabilitation specialist Median Kliniken, who is also an ex McKinsey & Company consultant and investment house managing director. A source tells us this is being done in anticipation of a sale.

Ramsay Sime Darby targeting $300m spin-off IPO

HBI understands that Malaysian/Indonesian hospital group Ramsay Sime Darby has appointed banks for a $300m IPO. One side of the JV says that expansion in healthcare is a key strategic focus, the other appears notably quiet about its investment in Asia. FY2020 saw profits drop for "the first time in many years" as COVID struck.

Waterland buys Priory, plans €2bn Median merger after propco sale

PE firm Waterland is buying UK mental health and adult specialist care operator The Priory Group from American Acadia Healthcare for €1.2bn and will merge it with existing portfolio company German rehab chain Median to create a c.€2bn revenue group, the sixth-largest for-profit acute operator in Europe by revenue. We talk to Waterland partner Dr Carsten Rahlfs and Median CEO Dr Andre Schmidt on the deal, plans with Priory and whether selling off the majority of its real estate to MPT is sensible.

Perella Weinberg sounds out buyers for $1bn+ NMC Health

Sell-side advisors Perella Weinberg are reportedly circulating teasers for in-administration international operator NMC Health's core GCC business with a view to a potential sale in April. We look at the potential for the potential new owners to consolidate the UAE hospital market.

Find Us